Science Daily reports on a study by University of Texas M. D. Anderson Cancer Centern titled "Neurofeedback reduces pain, increases quality of life for cancer patients suffering from chemotherapy-induced neuropathy"
Based on the description in the article, it sounds like this study used a traditional form of EEG Neurofeedback.
Some highlights from the article:
- Chronic chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapy.
- CIPN affects up to 96 percent of patients after a month of chemotherapy treatment.
- There were 71 participants with all types of cancer in this study.
- Seventy-three percent of participants saw improvement in their pain and quality of life.
- The neurofeedback reduced the intensity and unpleasantness of pain and numbness.
- The neurofeedback reduced how much pain interfered with daily activities.
- A study that will focus exclusively on breast cancer patients experiencing neuropathy was recently funded.